Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kyoko Nakanishi is active.

Publication


Featured researches published by Kyoko Nakanishi.


International Journal of Antimicrobial Agents | 2003

Alterations in penicillin binding protein gene of Streptococcus pneumoniae and their correlation with susceptibility patterns

Yoshinobu Ohsaki; Mineji Tachibana; Kyoko Nakanishi; Shoko Nakao; Kumiko Saito; Eri Toyoshima; Maki Sato; Toru Takahashi; Shinobu Osanai; Yoshihisa Itoh; Kenjiro Kikuchi

Penicillin binding protein (pbp) gene alterations of 328 clinical isolates of Streptococcus pneumoniae were examined for a correlation with their antibiotic-resistance. The frequency of penicillin G (PEN-G) resistance was determined to clarify susceptibility to several antibiotics, namely PEN-G, ampicillin, sulbactam/ampicillin, cefozopram, panipenem (PAPM), clarithromycin (CLR), azithromycin (AZM) and levofloxacin (LVX). Oligonucleotide primers for three pbp genes (pbp1a, pbp2x and pbp2b) were used to detect mutations in pbp. Of the strains, 25.9% were classified as Pen-Gs, 68.0% as Pen-Gir and 6.1% as Pen-Gr. The polymerase chain reaction product for wild-type pbp1a was found in 185 isolates, that for wild-type pbp2x was found in 66 isolates and that for wild-type pbp2b was found in 213 isolates. None of these three genes was detectable in 100 isolates while all of them were detected in 64 isolates (1aw/2xw/2bw). Of those 64 isolates with 1aw/2xw/2bw, the minimum inhibitory concentration (MIC) of PEN-G was < or =0.06 mg/l for 54 isolates and 0.12 mg/l for 10 isolates. Of the 272 strains for which the MIC of PAPM was < or =0.03 mg/l, there were 85 Pen-Gs, 184 Pen-Gir and three Pen-Gr isolates. Three strains for which the MIC of LVX was > or =4.0 mg/l included one Pen-Gs and two Pen-Gir isolates. The MICs of CLR correlated significantly with those of AZM. The MIC of CLR was > or =1 mg/l for 216 isolates, and the MIC of AZM was > or =1 mg/l for 244 of them. These data suggested that PAPM may be effective against S. pneumoniae infection, although acquisition of resistance should be considered. LVX also seemed to be effective against S. pneumoniae.


Diagnostic and Therapeutic Endoscopy | 2001

Detection of Photofrin Fluorescence From Malignant and Premalignant Lesions in the Bronchus using a Full-color Endoscopic Fluorescence Imaging System.

Yoshinobu Ohsaki; Kaneyoshi Takeyama; Shoko Nakao; Sachie Tanno; Eri Toyoshima; Kyoko Nakanishi; Yutaka Nishigaki; Toshiyuki Ogasa; Shinobu Osanai; Kenjiro Kikuchi; Susumu Nakajima

Study objectives: To detect invisible lung cancer and to determine field of laser radiation during PDT we developed a full-color fluorescence fiberscopic system. We tested the efficacy of this system in patients with various bronchial malignancies. System design: A fiber-optic endoscope was attached to a camera box containing a color ICCD camera which can detect from 400 to 700nm fluorescence in full-color. Light of average wavelength 405 nm was selected and radiated through the light channel of the fiberscope from a 300W Xenon lamp. Patients and methods: We examined nine consecutive patients with bronchial malignancy admitted in our hospital to receive PDT. Sixteen lesions in these nine patients were observed with white light and excitation light and the results were compared. Histological examinations were done by taking biopsy specimens and samples for pathological and cytological examination. After the diagnosis was confirmed, 2.0 mg/kg Photofrin was injected. Forty eight hours after the administration of Photofrin, observation of the bronchial wall was made using a full-color endoscopic fluorescence imaging system just before PDT. Results: Bright red fluorescence from Photofrin was Observed in 14/14 bronchial malignancies: 3 squamous cell carcinoma, 9 squamous cell carcinoma in situ, 1 metastatic breast cancer and 1 metastatic islet cell tumor. Bright red fluorescence was also detected in 2/2 squamous dysplasia. Green autofluorescence was observed in the normal part of the bronchus. Conclusions: Results of the present study suggest that the full-color endoscopic fluorescence imaging system can be used to detect malignant and premalignant lesions as red fluorescence against green autofluorescence with Photofrin administration, and this system has the potential to detect absence of autofluorescence in cancerous lesions.


Clinical Nuclear Medicine | 1997

Adult T-cell leukemia with invasion by malignant cells of both parotid glands diagnosed by an Ga-67 imaging : A case report

Jun Fukuzawa; Tadayuki Akaishi; Hideichi Tanaka; Kyoko Nakanishi; Motoi Okada; Takashi Haneda; Kenjiro Kikuchi

Adult T-cell leukemia (ATL) shows several initial symptoms such as lymphadenopathy. Although oral cavity dryness is uncommon as an initial symptom of ATL, the authors encountered a case of a 74-year-old man patient who complained of this initial symptom. Routine examinations and clinical course indicated that he was suffering from ATL. Further examination such as Ga-67 citrate scintigraphy and a postmortem study showed that this symptom had been induced by the invasion by ATL cells of the bilateral parotid glands. Therefore, ATL should be considered in patients with an initial symptom of oral cavity dryness and enlargement of the bilateral parotid glands.


Clinical Nuclear Medicine | 1996

Adult T-Cell Leukemia With Invasion by Malignant Cells of the Parotid Glands Diagnosed by Ga-67 Imaging

Jun Fukuzawa; Tadayuki Akaishi; Hideichi Tanaka; Kyoko Nakanishi; Motoi Okada; Takashi Haneda; Kenjiro Kikuchi

Adult T-cell leukemia (ATL) shows several initial signs such as lymphadenopathy. Although oral cavity dryness is uncommon as an initial symptom of ATL, we encountered a case of a man who complained of just such an initial symptom and routine examination and the clinical course indicated that he was suffering from ATL. Further examination with Ga-67 citrate scintigraphy and a post-mortem study showed that lymphadenopathy had been induced by invasion by ATL cells of both parotid glands. Therefore, ATL should be considered in patients with an initial symptom of oral cavity dryness and enlargement of the parotid glands.


Cancer Research | 2010

Abstract 903: Long-term survivors in advanced non-small cell lung cancer

Satoru Fujiuchi; Yuka Fujita; Yutaka Nishigaki; Kyoko Nakanishi; Yasushi Yamamoto; Akinori Takeda; Yasuhiro Yamazaki; Toshiaki Fujikane

Background: It is known that chemotherapy for advanced non small-cell lung cancer (NSCLC) improves the prognosis, however, with regard to 2-year survival rate of inoperable stage III/IV patients is up to 20%. The contribution of chemotherapies for survival is not fully satisfied yet. Purpose: The aim of this study is to evaluate the rate of long-term survival of more than 2 years in patients with advanced NSCLC and elucidate clinical factors that affect long-term survival in those patients. Methods: We retrospectively reviewed 103 patients with inoperable, stage III/IV NSCLC treated with chemotherapy from January 2005 to December 2006 at Dohoku National Hospital. These included 69 adenocarcinomas, 22 squamous cell carcinomas, 9 large cell carcinomas and 3 others. These patients were divided into two groups: those who survived more than 2 years (long-term survivors; LTS) and the others (non long-term survivors; non LTS). We analyzed the prognostic factors that affect the survival in this setting. The difference of characteristics between two groups was tested with the Mann-Whitney U test, the chi-square test or Fisher9s exact test. Survival curves were calculated according to Kaplan-Meier method. The correlations of variables with survival were analyzed by multivariate analysis using a Cox proportional hazards model. Results: There were 27 (26.2%) patients who survived more than 2 years (LTS). All of them had performance status (PS) 0 or 1. These LTS included 13 females, 11 non-smoker, 21 adenocarcinomas and 17 stage IV disease. LTS showed significant correlation with gender, smoking status, intrapulmonary metastases, response of 1st-line chemotherapy (SD or better), and response of gefitinib (SD or better) (p=0.0008, p=0.0457, p=0.0317, p=0.0004 and p=0.0026, respectively). Patients who respond to initial chemotherapy (SD or better) as well as gefitinib showed favorable course. Univariate analyses showed that PS 0-1, intrapulmonary metastases, response of 1st-line chemotherapy (SD or better), response of gefitinib (SD or better) were significantly associated with better prognosis (p=0.0036, p=0.0203, p Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 903.


Lung Cancer | 2004

Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3

Sachie Tanno; Yoshinobu Ohsaki; Kyoko Nakanishi; Eri Toyoshima; Kenjiro Kikuchi


Oncology Reports | 2004

Small cell lung cancer cells express EGFR and tyrosine phosphorylation of EGFR is inhibited by gefitinib (‘Iressa’, ZD1839)

Sachie Tanno; Yoshinobu Ohsaki; Kyoko Nakanishi; Eri Toyoshima; Kenjiro Kikuchi


Lung Cancer | 2005

Color auto-fluorescence from cancer lesions: Improved detection of central type lung cancer

Kyoko Nakanishi; Yoshinobu Ohsaki; Maki Kurihara; Shoko Nakao; Yuka Fujita; Kaneyoshi Takeyama; Shinobu Osanai; Naoyuki Miyokawa; Susumu Nakajima


Haigan | 2002

A Case of Spontaneous Regression of Small Cell Lung Cancer.

Kyoko Nakanishi; Yoshinobu Ohsaki; Shoko Nakao; Yoshihiko Tokusashi; Naoyuki Miyokawa; Kenjiro Kikuchi


The journal of the Japanese Respiratory Society | 2003

A case of pulmonary hamartoma and sclerosing hemangioma in the same lung

Sachie Tanno; Yoshinobu Ohsaki; Shoko Nakao; Kyoko Nakanishi; Shinobu Osanai; Naoyuki Miyokawa; Kenjiro Kikuchi

Collaboration


Dive into the Kyoko Nakanishi's collaboration.

Top Co-Authors

Avatar

Kenjiro Kikuchi

Asahikawa Medical College

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shinobu Osanai

Asahikawa Medical University

View shared research outputs
Top Co-Authors

Avatar

Shoko Nakao

Asahikawa Medical College

View shared research outputs
Top Co-Authors

Avatar

Eri Toyoshima

Asahikawa Medical College

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sachie Tanno

Asahikawa Medical College

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Satoru Fujiuchi

Asahikawa Medical College

View shared research outputs
Researchain Logo
Decentralizing Knowledge